A Study of an Existing Database to Assess the Treatment Persistence to Basal Insulin in Type 2 Diabetes Mellitus Patients in a Structured Patient Education Program in India (PERSISTENT)
Status
Conditions
Study type
Funder types
Identifiers
Details and patient eligibility
About
The aim of this study is to analyze data from an existing database named SAATH-7 Star, in order to assess the treatment persistence to basal insulin in Type 2 diabetes patients who had been enrolled in the SAATH-7 Star structured patient education program in India.
Full description
This retrospective study will involve secondary analysis of already existing data of Indian T2DM patients who were administered subcutaneous injectable solutions of insulin glargine (Lantus® or Toujeo®), as per routine clinical practice and who were enrolled in a structured educational program named SAATH-7 Star. Six-months data for eligible patients, who were enrolled in the SAATH-7 Star Program during the index period of March 2019-August 2019, collected from the SAATH-7 Star database will be analyzed for the defined objectives. The index date is defined as the date of enrollment in SAATH-7 Star program i.e. 1st month, which will also be considered as the 'Baseline'
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Male or female aged ≥ 18 years
- T2DM patients enrolled in SAATH-7 Star program during the index period from March 2019 to August 2019
Exclusion criteria
- Type 1 diabetes patients
- Patients with gestational diabetes
The above information is not intended to contain all considerations relevant to a potential participation in a clinical trial.
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal